For the younger adult age group (<60 years), we did not observe a significant effect of CMV status, although there is a clear trend towards a higher Spike-specific T cell response in seropositive mRNA-1273-vaccinated individuals.
← all excerpts
Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status.
1
—
—